Oxygen transport to mammalian cell and bacteria using nano-sized liposomes encapsulating oxygen molecules.

[1]  Yong Teng,et al.  Targeting Hypoxia-Driven Metabolic Reprogramming to Constrain Tumor Progression and Metastasis , 2020, International journal of molecular sciences.

[2]  Lei Sun,et al.  Biogenic nanobubbles for effective oxygen delivery and enhanced photodynamic therapy of cancer. , 2020, Acta biomaterialia.

[3]  P. Mi Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics , 2020, Theranostics.

[4]  Muhammad Saad Khan,et al.  Effective delivery of mycophenolic acid by oxygen nanobubbles for modulating immunosuppression , 2020, Theranostics.

[5]  N. Gu,et al.  Micro/nano-bubble-assisted ultrasound to enhance the EPR effect and potential theranostic applications , 2020, Theranostics.

[6]  M. Xie,et al.  Role of hypoxia in cancer therapy by regulating the tumor microenvironment , 2019, Molecular Cancer.

[7]  Muhammad Saad Khan,et al.  Anti-Tumor Drug-Loaded Oxygen Nanobubbles for the Degradation of HIF-1α and the Upregulation of Reactive Oxygen Species in Tumor Cells , 2019, Cancers.

[8]  B. Guery,et al.  Clostridioides difficile: diagnosis and treatments , 2019, BMJ.

[9]  Merel Kooi,et al.  Microplastics in freshwaters and drinking water: Critical review and assessment of data quality , 2019, Water research.

[10]  Xiaoyuan Chen,et al.  Ultrasound activation of liposomes for enhanced ultrasound imaging and synergistic gas and sonodynamic cancer therapy , 2019, Nanoscale Horizons.

[11]  M. Wheatley,et al.  Preserving the Integrity of Surfactant-Stabilized Microbubble Membranes for Localized Oxygen Delivery. , 2019, Langmuir : the ACS journal of surfaces and colloids.

[12]  Jong Seung Kim,et al.  Hypoxia-targeted drug delivery. , 2019, Chemical Society reviews.

[13]  S. Yao,et al.  pH-Responsive Oxygen Nanobubbles for Spontaneous Oxygen Delivery in Hypoxic Tumors. , 2019, Langmuir : the ACS journal of surfaces and colloids.

[14]  N. Forsyth,et al.  Hypoxia-Modified Cancer Cell Metabolism , 2019, Front. Cell Dev. Biol..

[15]  Muhammad Saad Khan,et al.  Surface Composition and Preparation Method for Oxygen Nanobubbles for Drug Delivery and Ultrasound Imaging Applications , 2019, Nanomaterials.

[16]  C. Lim,et al.  A 3D microvascular network model to study the impact of hypoxia on the extravasation potential of breast cell lines , 2018, Scientific Reports.

[17]  Jonghoon Choi,et al.  Oxygen-Carrying Micro/Nanobubbles: Composition, Synthesis Techniques and Potential Prospects in Photo-Triggered Theranostics , 2018, Molecules.

[18]  Muhammad Saad Khan,et al.  Engineering oxygen nanobubbles for the effective reversal of hypoxia , 2018, Artificial cells, nanomedicine, and biotechnology.

[19]  R. Advíncula,et al.  Role of Surface Tension in Gas Nanobubble Stability Under Ultrasound. , 2018, ACS applied materials & interfaces.

[20]  Zhigang Wang,et al.  Lipid Microbubbles as Ultrasound-Stimulated Oxygen Carriers for Controllable Oxygen Release for Tumor Reoxygenation. , 2018, Ultrasound in medicine & biology.

[21]  Jeffrey Farner Budarz,et al.  Microplastics and Nanoplastics in Aquatic Environments: Aggregation, Deposition, and Enhanced Contaminant Transport. , 2017, Environmental science & technology.

[22]  Yu Gao,et al.  Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer. , 2017, Biomaterials.

[23]  P. Stewart,et al.  Cryo-EM Visualization of Lipid and Polymer-Stabilized Perfluorocarbon Gas Nanobubbles - A Step Towards Nanobubble Mediated Drug Delivery , 2017, Scientific Reports.

[24]  Ji-Bin Liu,et al.  Sensitization of hypoxic tumors to radiation therapy using ultrasound sensitive oxygen microbubbles , 2017, 2017 IEEE International Ultrasonics Symposium (IUS).

[25]  C. Goergen,et al.  Oxygen nanobubbles revert hypoxia by methylation programming , 2017, Scientific Reports.

[26]  Lanlan Liu,et al.  Cancer Cell Membrane‐Biomimetic Oxygen Nanocarrier for Breaking Hypoxia‐Induced Chemoresistance , 2017 .

[27]  Chor Yong Tay,et al.  Gold Nanoparticles Induced Endothelial Leakiness Depends on Particle Size and Endothelial Cell Origin. , 2017, ACS nano.

[28]  John F. Callan,et al.  Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles , 2016, PloS one.

[29]  F. McGowan,et al.  Freeze-thawing at point-of-use to extend shelf stability of lipid-based oxygen microbubbles for intravenous oxygen delivery , 2016 .

[30]  Jing Wu,et al.  Doxorubicin nanobubble for combining ultrasonography and targeted chemotherapy of rabbit with VX2 liver tumor , 2016, Tumor Biology.

[31]  S. George,et al.  Vessel network formation in response to intermittent hypoxia is frequency dependent. , 2015, Journal of bioscience and bioengineering.

[32]  Andrew D. Wong,et al.  Quantitative Analysis of the Enhanced Permeation and Retention (EPR) Effect , 2015, PloS one.

[33]  R. Cavalli,et al.  2H,3H-Decafluoropentane-Based Nanodroplets: New Perspectives for Oxygen Delivery to Hypoxic Cutaneous Tissues , 2015, PloS one.

[34]  P. Choyke,et al.  Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates , 2014, Bioconjugate chemistry.

[35]  Colin R. Janssen,et al.  Microplastics in bivalves cultured for human consumption. , 2014, Environmental pollution.

[36]  S. Macip,et al.  The Role of the HIF-1α Transcription Factor in Increased Cell Division at Physiological Oxygen Tensions , 2014, PloS one.

[37]  David S. Park,et al.  Acidosis overrides oxygen deprivation to maintain mitochondrial function and cell survival , 2014, Nature Communications.

[38]  A. Zieseniss Hypoxia and the modulation of the actin cytoskeleton – emerging interrelations , 2014, Hypoxia.

[39]  Luis Solorio,et al.  Nanobubble Ultrasound Contrast Agents for Enhanced Delivery of Thermal Sensitizer to Tumors Undergoing Radiofrequency Ablation , 2014, Pharmaceutical Research.

[40]  R. Narayanaswamy,et al.  Gas detection using quenching fluorescence of dye-immobilised silica nanoparticles , 2013 .

[41]  Z. Binkhathlan,et al.  P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. , 2013, Current cancer drug targets.

[42]  Y. Sakai,et al.  Use of liposome encapsulated hemoglobin as an oxygen carrier for fetal and adult rat liver cell culture. , 2011, Journal of bioscience and bioengineering.

[43]  D. Weinberger,et al.  Degradation of HIF-1alpha under Hypoxia Combined with Induction of Hsp90 Polyubiquitination in Cancer Cells by Hypericin: a Unique Cancer Therapy , 2011, PloS one.

[44]  P. Ingham,et al.  Activation of hypoxia-inducible factor-1α (Hif-1α) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model. , 2011, Blood.

[45]  T. Matsushita,et al.  Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells. , 2011, Journal of bioscience and bioengineering.

[46]  M. Dewhirst,et al.  NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment , 2010, Proceedings of the National Academy of Sciences.

[47]  J. Briceño,et al.  Perfluorocarbon-based oxygen carriers: review of products and trials. , 2010, Artificial organs.

[48]  Mary A Sewell,et al.  Contributing to marine pollution by washing your face: microplastics in facial cleansers. , 2009, Marine pollution bulletin.

[49]  H. Maeda,et al.  Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[50]  Shufeng Zhou,et al.  Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[51]  K. Rock,et al.  The inflammatory response to cell death. , 2008, Annual review of pathology.

[52]  I. Tannock,et al.  Drug resistance and the solid tumor microenvironment. , 2007, Journal of the National Cancer Institute.

[53]  Thad Henkel-Honke,et al.  Artificial oxygen carriers: a current review. , 2007, AANA journal.

[54]  A. Harris,et al.  Role of hypoxia-inducible factor-1alpha as a cancer therapy target. , 2006, Endocrine-related cancer.

[55]  A. Greenburg,et al.  Artificial oxygen carriers as red blood cell substitutes: a selected review and current status. , 2004, Artificial organs.

[56]  E. Goetzl,et al.  The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. , 2001, Journal of molecular and cellular cardiology.

[57]  A. Fein,et al.  Cellular Oxygen Toxicity , 1996, The Journal of Biological Chemistry.

[58]  I. Tannock,et al.  Influence of hypoxia and an acidic environment on the metabolism and viability of cultured cells: potential implications for cell death in tumors. , 1986, Cancer research.

[59]  C. Winterford,et al.  Effects of hypoxia on morphological and biochemical characteristics of renal epithelial cell and tubule cultures. , 1992, Renal failure.